| human | Q5 |
| P269 | IdRef ID | 118909673 |
| P213 | ISNI | 0000000357040858 |
| P496 | ORCID iD | 0000-0003-4345-3598 |
| P214 | VIAF ID | 191851784 |
| P108 | employer | hôpital Foch | Q3145155 |
| P106 | occupation | researcher | Q1650915 |
| P5008 | on focus list of Wikimedia project | WikiProject COVID-19 | Q87748614 |
| P21 | sex or gender | male | Q6581097 |
| Q34524813 | A meta-analysis of the relationship between FGFR3 and TP53 mutations in bladder cancer. |
| Q30485050 | Assessment of oncologic control obtained after open versus laparoscopic nephroureterectomy for upper urinary tract urothelial carcinomas (UUT-UCs): results from a large French multicenter collaborative study. |
| Q53272755 | CDKN2A homozygous deletion is associated with muscle invasion in FGFR3-mutated urothelial bladder carcinoma. |
| Q37991060 | Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study |
| Q95646202 | Corrigendum to 'EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees' [European Urology 77 (2020) 223-2 |
| Q91384406 | EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort†: Under the Auspices of the EAU-ESMO Guidelines Committees |
| Q33229739 | Follow-up of renal oncocytoma diagnosed by percutaneous tumor biopsy. |
| Q92380749 | Grade groups at diagnosis in African Caribbean men with prostate cancer: Results of a comparative study |
| Q84798406 | High incidence of predominant Gleason pattern 4 localized prostate cancer is associated with low serum testosterone |
| Q47326814 | Idiopathic infantile bladder lithiasis from Roman antiquity. |
| Q42661049 | Influence of positive surgical margin status after radical nephroureterectomy on upper urinary tract urothelial carcinoma survival. |
| Q46924389 | MTOR inhibitors: from transplantation to oncology. AFU 2006 Transplantation Committee Review of the literature |
| Q81151744 | Morbidity of retropubic radical prostatectomy for prostate cancer in renal transplant recipients: multicenter study from Renal Transplantation Committee of French Urological Association |
| Q84916976 | Patterns of local recurrence after radical cystectomy in a contemporary series of patients with muscle-invasive bladder cancer |
| Q85011871 | Perivesical fat invasion in bladder cancer: implications for prognosis comparing pT2b, pT3a and pT3b stages and consequences for adjuvant chemotherapy indications |
| Q85918736 | Positive surgical margins and their locations in specimens are adverse prognosis features after radical cystectomy in non-metastatic carcinoma invading bladder muscle: results from a nationwide case-control study |
| Q38180522 | Postoperative nomogram to predict cancer-specific survival after radical nephroureterectomy in patients with localised and/or locally advanced upper tract urothelial carcinoma without metastasis |
| Q60907775 | Recurrent activating mutations of PPARγ associated with luminal bladder tumors |
| Q46647451 | Reduction of the renal transplantation cold ischaemia time by the use of a timesheet |
| Q43539210 | Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities? |
| Q51051457 | Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population. |
| Q80295534 | Renal transplantation and tumour transmission |
| Q58109456 | Sex steroids in serum and prostatic tissue of human cancerous prostate (STERKPROSER trial) |
| Q48348756 | Sexual steroids in serum and prostatic tissue of human non-cancerous prostate (STERPROSER trial). |
| Q83167971 | The Z-shaped ileal neobladder after radical cystectomy: an 18 years experience with 329 patients |
| Q39619988 | The role of American Society of Anesthesiologists scores in predicting urothelial carcinoma of the upper urinary tract outcome after radical nephroureterectomy: results from a national multi-institutional collaborative study. |
| Q83873667 | [ABO-incompatible renal transplantation] |
| Q80393609 | [Competitive morbidity in urologic cancer] |
| Q73857861 | [Contribution of laparoscopy to vesico-ureteral reimplantation on vesico-psoas] |
| Q86246994 | [Diagnosis and management of severe adverse events occurring during BCG therapy for non-muscle invasive bladder cancer (NMIBC)] |
| Q79840957 | [How to anticipate specialization at the Examen National Classant (National Entrance Examination) to encourage interns to choose urology] |
| Q82774136 | [In vivo comparison of preservation of murine islets of Langerhans] |
| Q82774076 | [Intravesical BCG instillations for the treatment of superficial bladder tumours in renal transplant recipients] |
| Q54243542 | [Is the surgical training of French urologists more effective than that of urologists in other European countries?]. |
| Q33202031 | [Limited prognostic value of surgical biopsy before transplantation of good quality renal transplants]. |
| Q90732407 | [Recommendations CCAFU on the management of cancers of the urogenital system during an epidemic with Coronavirus COVID-19] |
| Q79990270 | [Renal cancer and second cancer: critical review of the literature] |
| Q81928156 | [Renal oncocytoma associated with renal cell carcinoma] |
| Q83873658 | [Renal oncocytoma] |
| Q80154511 | [Renal tumours] |
| Q79840945 | [Study of urothelial bladder tumours in renal transplant recipients] |
| Q81543867 | [Urinary stones in subjects over the age of sixty] |
Search more.